Product Overview:
CJC-1295 without DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), designed to stimulate the natural release of growth hormone (GH) from the pituitary gland. Unlike the DAC-modified version, this form of CJC-1295 has a much shorter half-life, leading to a rapid but transient pulse of GH release.
This short-acting version is frequently used in studies where precise control over GH pulses is desired, often in combination with other secretagogues such as GHRPs or Ipamorelin to mimic the body’s natural growth hormone secretion rhythm.
Key areas of research include:
-
Acute GH and IGF-1 response studies
-
Short-duration pituitary stimulation models
-
Muscle growth and recovery investigations
-
Metabolic regulation and anti-aging research
-
Combination peptide protocols with GHRPs
Applications in Research:
-
Exploration of short-acting GHRH analogs
-
Studies on pulsatile GH release dynamics
-
Investigations into pituitary feedback mechanisms
-
Synergistic applications with GHRPs and secretagogues
Storage & Handling:
Store lyophilized peptide at -20°C, away from light and moisture. Reconstitute with sterile bacteriostatic water for laboratory use. After reconstitution, refrigerate and use within appropriate timeframes. Avoid multiple freeze-thaw cycles.




